Treatment of dengue fever

References

• WeaverSCVasilakisNMolecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral diseaseInfect Genet Evol2009952354019460319
   PubMed Web of Science ®Google Scholar
• ThomasSJStrickmanDVaughnDWDengue epidemiology: virus epidemiology, ecology, and emergenceAdv Virus Res20036123528914714434
   PubMedGoogle Scholar
• SanchezVGimenezSTomlinsonBInnate and adaptive cellular immunity in flavivirus-naive human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3)Vaccine2006244914492616632108
   PubMed Web of Science ®Google Scholar
• MesserWBVitaranaUTSivananthanKEpidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic feverAm J Trop Med Hyg20026676577312224589
   PubMed Web of Science ®Google Scholar
• GuptaEDarLKapoorGBroorSThe changing epidemiology of dengue in Delhi, IndiaVirol J200639217083743
   PubMed Web of Science ®Google Scholar
• RajapakseSIntravenous immunoglobulins in the treatment of dengue illnessTrans R Soc Trop Med Hyg200910386787019203771
   PubMed Web of Science ®Google Scholar
• RajapakseSCorticosteroids in the treatment of dengue illnessTrans R Soc Trop Med Hyg200910312212618789467
   PubMed Web of Science ®Google Scholar
• SimasathienSWatanaveeradejVDengue vaccineJ Med Assoc Thai200588Suppl 3S363S37716858980
   PubMedGoogle Scholar
• World Health OrganizationDengue: Guidelines for diagnosis, treatment, prevention and control Available at: http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdfAccessed June 13, 2012
   Google Scholar
• JelinekTTrends in the epidemiology of dengue fever and their relevance for importation to EuropeEuro Surveill200914251925019555595
   PubMedGoogle Scholar
• Centers for Disease Control and PreventionDengue fever and dengue hemorrhagic fever Available at: http://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/dengue-fever-and-dengue-hemorrhagic-fever.htmAccessed June 13, 2012
   Google Scholar
• KalayanaroojSVaughnDWNimmannityaSEarly clinical and laboratory indicators of acute dengue illnessJ Infect Dis19971763133219237695
   PubMed Web of Science ®Google Scholar
• StephensonJRUnderstanding dengue pathogenesis: implications for vaccine designBull World Health Organ20058330831415868023
   PubMed Web of Science ®Google Scholar
• Ministry of HealthNational Guidelines on Management of Dengue Fever and Hemorrhagic Fever in adults and childrenColombo, Sri LankaMinistry of Health2011
   Google Scholar
• PremaratnaRLiyanaarachchiEWeerasingheMde SilvaHJShould colloid boluses be prioritized over crystalloid boluses for the management of dengue shock syndrome in the presence of ascites and pleural effusions?BMC Infect Dis2011115221356095
   PubMed Web of Science ®Google Scholar
• NimmannityaSClinical spectrum and management of dengue haemorrhagic feverSoutheast Asian J Trop Med Public Health1987183923973433169
   PubMedGoogle Scholar
• DungNMDayNPTamDTFluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimensClin Infect Dis19992978779410589889
   PubMed Web of Science ®Google Scholar
• NgoNTCaoXTKneenRAcute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hourClin Infect Dis20013220421311170909
   PubMed Web of Science ®Google Scholar
• WillsBANguyenMDHaTLComparison of three fluid solutions for resuscitation in dengue shock syndromeN Engl J Med200535387788916135832
   PubMed Web of Science ®Google Scholar
• IsarangkuraPTuchindaSThe behavior of transfused platelets in dengue hemorrhagic feverSoutheast Asian J Trop Med Public Health199324Suppl 12222247886581
   PubMedGoogle Scholar
• SellahewaKHSamaraweeraNThusitaKPFernandoJLIs fresh frozen plasma effective for thrombocytopenia in adults with dengue fever? A prospective randomised double blind controlled studyCeylon Med J200853364018678119
   PubMedGoogle Scholar
• WeerakoonKGKularatneSAEdussuriyaDHHistopathological diagnosis of myocarditis in a dengue outbreak in Sri Lanka, 2009BMC Res Notes2011426821798066
   PubMedGoogle Scholar
• GhoshMBanerjeeMDasSChakrabortySDengue infection with multi-organ involvementScand J Infect Dis20114331631821128707
   PubMed Web of Science ®Google Scholar
• KuraneIDengue hemorrhagic fever with special emphasis on immunopathogenesisComp Immunol Microbiol Infect Dis20073032934017645944
   PubMed Web of Science ®Google Scholar
• PanpanichRSornchaiPKanjanaratanakornKCorticosteroids for treating dengue shock syndromeCochrane Database Syst Rev20063CD00348816856011
   PubMedGoogle Scholar
• SrichaikulTPunyaguptaSSorakhunpipitkulLUdomsubpayakulUAdjunctive corticosteroid therapy in 149 grade II (non-shock) adult DHF patients: an analysis during January 2008-February 2010J Med Assoc Thai20119414192322295726
   PubMedGoogle Scholar
• KularatneSAWalatharaCMahindawansaSIEfficacy of low dose dexamethasone in severe thrombocytopenia caused by dengue fever: a placebo controlled studyPostgrad Med J20098552552919789191
   PubMed Web of Science ®Google Scholar
• PremaratnaRJayasingheKGLiyanaarachchiEWWeerasingheOMPathmeswaranAde SilvaHJEffect of a single dose of methyl prednisolone as rescue medication for patients who develop hypotensive dengue shock syndrome during the febrile phase: a retrospective observational studyInt J Infect Dis201115e433e43421530348
   PubMed Web of Science ®Google Scholar
• KularatneSASurvey on the management of dengue infection in Sri Lanka: opinions of physicians and pediatriciansSoutheast Asian J Trop Med Public Health2005361198120016438145
   PubMedGoogle Scholar
• RajapakseSRanasingheCRodrigoCCorticosteroid therapy in dengue infection – opinions of junior doctorsJ Glob Infect Dis2010219920020606983
   PubMedGoogle Scholar
• OstronoffMOstronoffFFlorencioRSerious thrombocytopenia due to dengue hemorrhagic fever treated with high dosages of immunoglobulinClin Infect Dis2003361623162412802766
   PubMed Web of Science ®Google Scholar
• DimaanoEMSaitoMHondaSLack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infectionAm J Trop Med Hyg2007771135113818165536
   PubMed Web of Science ®Google Scholar
• CamBVTuanDTFonsmarkLRandomized comparison of oxygen mask treatment vs nasal continuous positive airway pressure in dengue shock syndrome with acute respiratory failureJ Trop Pediatr20024833533912521274
   PubMed Web of Science ®Google Scholar
• SendoTItohYAkiKOkaMOishiRCarbazochrome sodium sulfonate (AC-17) reverses endothelial barrier dysfunction through inhibition of phosphatidylinositol hydrolysis in cultured porcine endothelial cellsNaunyn Schmiedebergs Arch Pharmacol200336817518012928765
   PubMed Web of Science ®Google Scholar
• TassniyomSVasanawathanaSDhiensiriTNisalakAChirawatkulAFailure of carbazochrome sodium sulfonate (AC-17) to prevent dengue vascular permeability or shock: a randomized, controlled trialJ Pediatr19971315255289386652
   PubMed Web of Science ®Google Scholar
• ThomasSJEndyTPCritical issues in dengue vaccine developmentCurr Opin Infect Dis20112444245021799408
   PubMed Web of Science ®Google Scholar
• RaviprakashKWangDEwingDA tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virusJ Virol2008826927693418480438
   PubMed Web of Science ®Google Scholar
• SabinABResearch on dengue during World War IIAm J Trop Med Hyg19521305014903434
   PubMedGoogle Scholar
• HalsteadSBEpidemiological studies of Thai haemorrhagic feverBull World Health Organ196635808120604279
   PubMed Web of Science ®Google Scholar
• RothmanALCellular immunology of sequential dengue virus infection and its role in disease pathogenesisCurr Top Microbiol Immunol2010338839819802580
   PubMed Web of Science ®Google Scholar
• LinCCHuangYHShuPYCharacteristic of dengue disease in TaiwanAm J Trop Med Hyg20108273173920348527
   PubMed Web of Science ®Google Scholar
• KliksSCNimmannityaSNisalakABurkeDSEvidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infantsAm J Trop Med Hyg1988384114193354774
   PubMed Web of Science ®Google Scholar
• HalsteadSBMahalingamSMarovichMAIntrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexesLancet Infect Dis20101071272220883967
   PubMed Web of Science ®Google Scholar
• HalsteadSBNimmannityaSCohenSNObservations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recoveredYale J Biol Med1970423113285419206
   PubMed Web of Science ®Google Scholar
• RaviprakashKDefangGBurgessTPorterKAdvances in dengue vaccine developmentHum Vaccin2009552052819535912
   PubMed Web of Science ®Google Scholar
• ChenLEwingDSubramanianHA heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaquesJ Virol200781116341163917715224
   PubMed Web of Science ®Google Scholar
• RaviprakashKAptDBrinkmanAA chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaquesVirology200635316617316814355
   PubMed Web of Science ®Google Scholar
• ThomasSJThe necessity and quandaries of dengue vaccine developmentJ Infect Dis201120329930321208919
   PubMed Web of Science ®Google Scholar
• LeeBYConnorDLKitchenSBEconomic value of dengue vaccine in ThailandAm J Trop Med Hyg20118476477221540387
   PubMed Web of Science ®Google Scholar
• SimasathienSThomasSJWatanaveeradejVSafety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive childrenAm J Trop Med Hyg20087842643318337339
   PubMed Web of Science ®Google Scholar
• WatanaveeradejVSimasathienSNisalakASafety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirusnaive infantsAm J Trop Med Hyg20118534135121813857
   PubMed Web of Science ®Google Scholar
• SabchareonALangJChanthavanichPYoksanSForratRAttanathPSafety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio and multiple dosesAm J Trop Med Hyg20026626427212139219
   PubMed Web of Science ®Google Scholar